| Phase 11 trial |
|
Phase 1
|
NCT06383871 |
Jun 2024 → Jun 2026 overdue |
cancer |
Shandong Suncadia Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
| Phase 25 trials |
|
Phase 2
|
NCT07704645 |
Aug 2026 → Jun 2028 expected |
non-small cell lung carcinoma |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07589569 |
Jun 2026 → Dec 2028 expected |
malignant pancreatic neoplasm |
Shandong Suncadia Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07503639 |
Apr 2026 → Apr 2028 expected |
colorectal cancer |
Fudan University |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07032077 |
Jul 2025 → Jun 2027 expected |
cancer |
Shandong Suncadia Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06915142 |
Apr 2025 → Dec 2026 expected |
cancer |
Shandong Suncadia Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT07601048 |
Jun 2026 → May 2028 expected |
— |
Shandong Suncadia Medicine Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|